Can Fatty Liver Cause Low Iron? UK Guide

Fatty liver disease and low iron levels are linked through the liver's central role in iron regulation, making this a clinically important relationship to understand. Fatty liver disease, increasingly known as metabolic dysfunction-associated steatotic liver disease (MASLD), affects a significant proportion of UK adults and can disrupt iron metabolism through inflammation, altered hepcidin production, and impaired liver function. Whether this leads to iron deficiency or, in some cases, iron overload depends on individual factors. This article explains the mechanisms involved, the symptoms to watch for, how UK doctors investigate both conditions, and what treatments and dietary changes may help.

Can fatty liver disease cause low iron levels?

Fatty liver disease can cause functional iron deficiency by raising hepcidin levels, which suppresses iron absorption and traps iron in cells, though some individuals develop iron overload instead.

Fatty liver disease can contribute to low iron levels through several interconnected mechanisms, although the relationship is complex and not always straightforward. Non-alcoholic fatty liver disease (NAFLD), now increasingly referred to as metabolic dysfunction-associated steatotic liver disease (MASLD), is the most common chronic liver condition in the UK. NHS and British Liver Trust estimates suggest it affects a substantial proportion of adults, with figures often cited in the range of one in three to one in four, though prevalence varies depending on the diagnostic criteria used.

The liver plays a central role in iron metabolism. It produces hepcidin, a hormone that regulates how much iron is absorbed from the gut and released from storage cells.^[5][6] In people with fatty liver disease, chronic low-grade inflammation can raise hepcidin levels, which in turn suppresses iron absorption and traps iron inside cells, reducing the amount available in the bloodstream. This pattern is sometimes described as anaemia of chronic disease or functional iron deficiency, where total body iron stores may be normal or even elevated, yet iron is not being used effectively.

Conversely, some people with fatty liver disease develop iron overload rather than deficiency. Raised ferritin is common in MASLD and does not always indicate true iron overload; this pattern is sometimes called dysmetabolic hyperferritinaemia.^[8][9] People with a genetic predisposition such as hereditary haemochromatosis are at particular risk of genuine iron excess. This highlights why individual assessment is essential rather than assuming a single direction of effect. Alcohol-related liver disease can also disrupt iron balance through different pathways, including poor dietary intake and impaired liver function.

Because the liver is so central to iron regulation, any significant liver condition warrants careful monitoring of iron status. If you have been diagnosed with fatty liver disease and are experiencing symptoms that might suggest low iron, speaking to your GP is the appropriate first step.

What are the signs that your iron levels might be low?

Common signs of low iron include persistent fatigue, pale skin, shortness of breath, brittle nails, and difficulty concentrating; in liver disease these symptoms can be easily misattributed without blood testing.

The most common signs of low iron levels include persistent fatigue, weakness, pale skin, shortness of breath on exertion, and difficulty concentrating. These symptoms arise because iron is essential for producing haemoglobin, the protein in red blood cells that carries oxygen around the body. When iron is insufficient, red blood cells become smaller and less effective, a condition known as iron deficiency anaemia.^[1]

In people with fatty liver disease, these symptoms can be particularly easy to overlook or misattribute. Fatigue and reduced exercise tolerance are also common features of liver disease itself, meaning that low iron may go unrecognised without specific blood testing. Other signs that may point towards iron deficiency include:

• Brittle nails or a spoon-shaped nail deformity (koilonychia)

• Unusual cravings for non-food substances such as ice or clay (pica)

• A sore or swollen tongue

• Headaches and dizziness

• Restless legs, particularly at night

• Feeling cold more easily than usual

It is worth noting that not everyone with low iron will have obvious symptoms, especially in the early stages. Some people only discover a problem through routine blood tests.

Seek urgent medical attention if you experience any of the following, as these may indicate gastrointestinal bleeding or severe anaemia requiring prompt assessment: black or tarry stools (melaena), vomiting blood, unexplained rectal bleeding, fainting or collapse, new or worsening chest pain, or severe breathlessness at rest. These symptoms require same-day assessment and you should call 999 or go to your nearest emergency department.

In the context of liver disease, symptoms such as jaundice, abdominal discomfort, or swelling are more likely to be related to the liver condition itself and should be assessed by a doctor promptly.

If you notice any of the symptoms listed above, particularly alongside a known diagnosis of fatty liver disease, contact your GP for assessment. Confirmed iron deficiency anaemia in adults requires investigation for an underlying cause, including coeliac disease and, in adult men and post-menopausal women, gastrointestinal blood loss.^[14] Do not attempt to self-treat with iron supplements without medical advice, as excess iron can be harmful, particularly in liver disease.

How do doctors in the UK test for iron deficiency alongside liver disease?

UK doctors use a full blood count, serum ferritin, serum iron, and transferrin saturation to assess iron status; ferritin alone can be misleading in liver disease due to inflammation, so transferrin saturation is also measured.

UK doctors typically investigate iron deficiency and liver disease together using a combination of blood tests, guided by NICE guidelines and clinical judgement. A full blood count (FBC) is usually the starting point, which can reveal whether red blood cells are smaller or paler than normal, a pattern consistent with iron deficiency anaemia. However, in people with liver disease, the picture can be complicated by other factors such as vitamin B12 or folate deficiency, alcohol use, or the anaemia of chronic disease.

To assess iron status more precisely, doctors will often request a serum ferritin level alongside serum iron and transferrin saturation. Ferritin reflects iron stores, but it is also an acute-phase protein, meaning it rises during inflammation. In fatty liver disease, ferritin may appear falsely normal or elevated even when functional iron deficiency is present. A C-reactive protein (CRP) level can help interpret ferritin in this context. Low transferrin saturation alongside a normal or raised ferritin suggests functional iron deficiency rather than true iron excess. This is why transferrin saturation, which measures how much of the iron-carrying protein is actually loaded with iron, provides additional useful information.

Liver function tests (LFTs), including alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyl transferase (GGT), are routinely checked to assess the degree of liver involvement. In some cases, a FibroScan or liver biopsy may be recommended to evaluate the extent of liver damage. NICE guidance on NAFLD (NG49) supports the use of non-invasive fibrosis assessment tools, including the Enhanced Liver Fibrosis (ELF) test, to stratify risk; your GP or specialist will determine which approach is most appropriate based on current local pathways.^[3][4] If haemochromatosis is suspected, genetic testing for the HFE gene mutation may be offered.

Where iron deficiency anaemia is confirmed, UK standard practice (per British Society of Gastroenterology and British Society for Haematology guidance) includes coeliac serology and, in adult men and post-menopausal women, consideration of gastrointestinal investigation to exclude blood loss.

Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online health consultations, with prescriber review and pharmacist support. Investigation of liver and iron conditions requires face-to-face NHS assessment and cannot be managed through an online pharmacy alone.

What treatments and dietary changes can help manage both conditions?

Treatment depends on the underlying cause; dietary iron from red meat, legumes, and dark leafy vegetables is a first step, with oral iron supplements prescribed under medical supervision if dietary measures are insufficient.

Managing low iron alongside fatty liver disease requires a tailored approach that addresses both conditions without worsening either. The treatment of iron deficiency depends on its underlying cause and severity. Where dietary intake is insufficient, increasing consumption of iron-rich foods is a sensible first step. Good dietary sources of iron include:

• Red meat, poultry, and oily fish

• Legumes such as lentils, chickpeas, and kidney beans

• Dark leafy vegetables including spinach and kale

• Fortified breakfast cereals

• Tofu and tempeh

Consuming vitamin C alongside iron-rich plant foods improves absorption, while tea, coffee, and calcium-rich foods consumed at the same time can reduce it.^[15][16] For people with fatty liver disease, a Mediterranean-style diet is broadly supported by NHS and NICE guidance, as it helps support liver health, reduces inflammation, and provides a good range of micronutrients including iron.^[3][19]

Where dietary measures are insufficient, oral iron supplements such as ferrous sulfate or ferrous fumarate may be prescribed by a GP. These are typically taken on an empty stomach or with a small amount of food if gastrointestinal upset occurs. Common side effects include nausea, constipation, and dark stools. Oral iron should only be taken under medical supervision in the context of liver disease, as iron overload can accelerate liver damage. Per British Society for Haematology guidance, a rise in haemoglobin is usually expected within two to four weeks of starting treatment, and therapy is generally continued for around three months after levels normalise to replenish stores.^[14] In cases of severe deficiency, poor oral tolerance, or ongoing blood loss, intravenous iron infusion may be considered in secondary care; this is administered in a clinical setting equipped to manage the small risk of hypersensitivity reactions.

If you experience unexpected symptoms while taking iron supplements or any other prescribed medicine, you can report these to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

For fatty liver disease itself, the most evidence-based interventions remain weight loss of around 7 to 10 per cent of body weight where overweight or obesity is present (with greater weight loss associated with greater histological benefit in some studies), regular physical activity, and avoidance of alcohol.^[23] These targets are consistent with NHS and NICE lifestyle recommendations for NAFLD and MASLD. There are currently no MHRA-authorised medicines specifically licensed for NAFLD or MASLD in the UK, though several are under investigation; this position should be confirmed with your GP or specialist as the regulatory landscape may change. Managing associated conditions such as type 2 diabetes, high blood pressure, and raised cholesterol is also central to reducing liver disease progression. Regular follow-up with your GP or a hepatology team ensures both conditions are monitored appropriately over time.

Scientific References

1. Iron deficiency anaemia.
2. Non-alcoholic fatty liver disease (NAFLD).
3. Metabolic dysfunction-associated steatotic liver disease (NG49).
4. Metabolic dysfunction-associated steatotic liver disease – recommendations for research (NG49).
5. Regulation of iron metabolism by hepcidin.
6. Cyclical Iron Homeostasis: The Role of Sex Hormones in Female Iron Regulation.
7. FGL1-hepcidin axis in iron homeostasis and disease.
8. Non-invasive methods for iron overload evaluation in dysmetabolic patients.
9. Dysmetabolic Hyperferritinemia and Dysmetabolic Iron Overload Syndrome (DIOS): Two Related Conditions or Different Entities?.
10. The role of biomarkers for the acute phase response in assessing iron status.
11. Characteristics of transferrin saturation and anemia-related biomarkers in patients with uterine adenomyosis.
12. Hyperferritinemia: Important Differentials for the Rheumatologists.
13. Koilonychia in Iron-Deficiency Anemia.
14. British Society of Gastroenterology guidelines for the management of iron deficiency anaemia.
15. Effect of tea and other dietary factors on iron absorption.
16. Interaction of vitamin C and iron.
17. Iron Absorption: Factors, Limitations, and Improvement Methods.
18. Enhanced liver fibrosis test for the non-invasive diagnosis of advanced fibrosis in NAFLD.
19. Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in MASLD: a systematic review and meta-analysis.
20. Effects of Mediterranean diet and low-fat diet on liver enzymes and liver fat content of NAFLD: systematic review and meta-analysis.
21. Resmetirom (Rezdiffra) authorised to treat metabolic dysfunction-associated steatohepatitis (MASH) in adults.
22. GID-TA11477 draft scope – no medicines approved for MASLD or MASH in the UK.
23. The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: a systematic review and meta-analysis.
24. Intravenous iron and serious hypersensitivity reactions: strengthened recommendations.
25. Real-world experience of intravenous ferric derisomaltose evaluated through safety and efficacy reporting in the UK.

Frequently Asked Questions